CKD Corporation Logo

CKD Corporation

6407.T

(2.2)
Stock Price

2.926,00 JPY

5.8% ROA

8.17% ROE

14.77x PER

Market Cap.

173.942.580.384,00 JPY

30.28% DER

2.82% Yield

7.12% NPM

CKD Corporation Stock Analysis

CKD Corporation Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

CKD Corporation Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a minimal amount of debt (15%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

2 ROE

The stock's ROE falls within an average range (12.8%), demonstrating satisfactory profitability and efficiency in utilizing shareholders' equity.

3 ROA

The stock's ROA (8.41%) shows that it's doing a pretty good job at making money from its assets, making it a solid choice to invest and earn steady profits.

4 PBV

The stock's PBV ratio (1.28x) reflects a fair valuation, making it an attractive option for investors seeking balanced opportunities.

5 Assets Growth

With a track record of continuous revenue growth in the last three years, this company offers a promising investment opportunity

6 Graham Number

The Graham number analysis indicates that this company's stock price is likely undervalued, raising prospects for a favorable investment opportunity.

7 Dividend

The company's history of regular dividend distributions in the last three years showcases its ability to generate reliable income for shareholders.

8 Buffet Intrinsic Value

The company's stock shows potential as it is undervalued (32.988) according to Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.

9 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

10 Net Profit Growth

This company's net profit has remained stagnant over the past five years, indicating a lack of growth and making it a less favorable investment option.

11 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

CKD Corporation Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

CKD Corporation Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

CKD Corporation Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

CKD Corporation Revenue
Year Revenue Growth
2004 77.204.000.000
2005 84.312.000.000 8.43%
2006 104.262.000.000 19.13%
2007 93.705.000.000 -11.27%
2008 68.175.000.000 -37.45%
2009 50.035.000.000 -36.25%
2010 72.020.000.000 30.53%
2011 72.804.000.000 1.08%
2012 65.031.000.000 -11.95%
2013 75.491.000.000 13.86%
2014 83.379.000.000 9.46%
2015 88.117.000.000 5.38%
2016 94.012.000.000 6.27%
2017 115.700.000.000 18.75%
2018 115.665.000.000 -0.03%
2019 100.717.000.000 -14.84%
2020 106.723.000.000 5.63%
2021 142.199.000.000 24.95%
2022 159.457.000.000 10.82%
2023 133.984.000.000 -19.01%
2023 134.425.000.000 0.33%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

CKD Corporation Research and Development Expenses
Year Research and Development Expenses Growth
2004 2.470.000.000
2005 2.419.000.000 -2.11%
2006 2.664.000.000 9.2%
2007 2.443.000.000 -9.05%
2008 2.149.000.000 -13.68%
2009 1.731.000.000 -24.15%
2010 2.245.000.000 22.9%
2011 2.151.000.000 -4.37%
2012 2.336.000.000 7.92%
2013 2.709.000.000 13.77%
2014 2.927.000.000 7.45%
2015 2.857.000.000 -2.45%
2016 3.348.000.000 14.67%
2017 4.330.000.000 22.68%
2018 3.637.000.000 -19.05%
2019 3.383.000.000 -7.51%
2020 3.578.000.000 5.45%
2021 3.639.000.000 1.68%
2022 3.808.000.000 4.44%
2023 0 0%
2023 3.554.000.000 100%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

CKD Corporation General and Administrative Expenses
Year General and Administrative Expenses Growth
2004 2.088.000.000
2005 2.128.000.000 1.88%
2006 2.748.000.000 22.56%
2007 2.400.000.000 -14.5%
2008 1.819.000.000 -31.94%
2009 1.103.000.000 -64.91%
2010 1.484.000.000 25.67%
2011 1.490.000.000 0.4%
2012 1.463.000.000 -1.85%
2013 1.565.000.000 6.52%
2014 1.968.000.000 20.48%
2015 1.998.000.000 1.5%
2016 2.191.000.000 8.81%
2017 3.175.000.000 30.99%
2018 3.181.000.000 0.19%
2019 2.596.000.000 -22.53%
2020 2.749.000.000 5.57%
2021 3.265.000.000 15.8%
2022 3.838.000.000 14.93%
2023 0 0%
2023 3.429.000.000 100%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

CKD Corporation EBITDA
Year EBITDA Growth
2004 12.016.000.000
2005 13.842.000.000 13.19%
2006 18.131.000.000 23.66%
2007 15.436.000.000 -17.46%
2008 6.415.000.000 -140.62%
2009 5.215.000.000 -23.01%
2010 12.129.000.000 57%
2011 11.120.000.000 -9.07%
2012 6.209.000.000 -79.09%
2013 10.684.000.000 41.89%
2014 11.806.000.000 9.5%
2015 12.119.000.000 2.58%
2016 13.817.000.000 12.29%
2017 16.863.000.000 18.06%
2018 10.798.000.000 -56.17%
2019 11.312.000.000 4.54%
2020 13.436.000.000 15.81%
2021 24.266.000.000 44.63%
2022 28.299.000.000 14.25%
2023 13.060.000.000 -116.68%
2023 19.943.000.000 34.51%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

CKD Corporation Gross Profit
Year Gross Profit Growth
2004 22.898.000.000
2005 23.903.000.000 4.2%
2006 29.099.000.000 17.86%
2007 25.222.000.000 -15.37%
2008 15.796.000.000 -59.67%
2009 11.421.000.000 -38.31%
2010 20.657.000.000 44.71%
2011 19.656.000.000 -5.09%
2012 17.023.000.000 -15.47%
2013 23.152.000.000 26.47%
2014 25.440.000.000 8.99%
2015 26.735.000.000 4.84%
2016 28.728.000.000 6.94%
2017 35.836.000.000 19.83%
2018 28.511.000.000 -25.69%
2019 26.136.000.000 -9.09%
2020 28.773.000.000 9.16%
2021 40.891.000.000 29.63%
2022 46.398.000.000 11.87%
2023 37.440.000.000 -23.93%
2023 37.036.000.000 -1.09%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

CKD Corporation Net Profit
Year Net Profit Growth
2004 4.015.000.000
2005 5.182.000.000 22.52%
2006 7.541.000.000 31.28%
2007 5.546.000.000 -35.97%
2008 -2.849.000.000 294.66%
2009 1.494.000.000 290.7%
2010 4.577.000.000 67.36%
2011 3.741.000.000 -22.35%
2012 2.452.000.000 -52.57%
2013 5.456.000.000 55.06%
2014 6.010.000.000 9.22%
2015 5.459.000.000 -10.09%
2016 6.958.000.000 21.54%
2017 9.142.000.000 23.89%
2018 4.793.000.000 -90.74%
2019 3.689.000.000 -29.93%
2020 5.273.000.000 30.04%
2021 12.567.000.000 58.04%
2022 14.788.000.000 15.02%
2023 8.360.000.000 -76.89%
2023 8.338.000.000 -0.26%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

CKD Corporation Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2004 65
2005 82 21.95%
2006 114 28.07%
2007 85 -35.71%
2008 -45 286.67%
2009 24 287.5%
2010 73 67.12%
2011 59 -25.86%
2012 39 -52.63%
2013 87 56.32%
2014 96 9.38%
2015 88 -10.34%
2016 112 22.32%
2017 148 23.81%
2018 77 -90.91%
2019 60 -30.51%
2020 80 26.25%
2021 189 57.45%
2022 222 14.93%
2023 0 0%
2023 125 100%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

CKD Corporation Free Cashflow
Year Free Cashflow Growth
2004 5.397.000.000
2005 369.000.000 -1362.6%
2006 4.006.000.000 90.79%
2007 1.528.000.000 -162.17%
2008 23.000.000 -6543.48%
2009 6.858.000.000 99.66%
2010 3.047.000.000 -125.07%
2011 544.000.000 -460.11%
2012 4.018.000.000 86.46%
2013 5.907.000.000 31.98%
2014 182.000.000 -3145.6%
2015 471.000.000 61.36%
2016 4.921.000.000 90.43%
2017 -2.586.000.000 290.29%
2018 -18.564.000.000 86.07%
2019 13.169.000.000 240.97%
2020 14.563.000.000 9.57%
2021 4.115.000.000 -253.9%
2022 -702.000.000 686.18%
2023 0 0%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

CKD Corporation Operating Cashflow
Year Operating Cashflow Growth
2004 7.473.000.000
2005 3.940.000.000 -89.67%
2006 7.715.000.000 48.93%
2007 10.113.000.000 23.71%
2008 2.183.000.000 -363.26%
2009 7.775.000.000 71.92%
2010 4.048.000.000 -92.07%
2011 3.775.000.000 -7.23%
2012 7.008.000.000 46.13%
2013 9.754.000.000 28.15%
2014 6.226.000.000 -56.67%
2015 8.027.000.000 22.44%
2016 10.163.000.000 21.02%
2017 5.542.000.000 -83.38%
2018 -2.254.000.000 345.87%
2019 17.250.000.000 113.07%
2020 17.521.000.000 1.55%
2021 12.352.000.000 -41.85%
2022 11.049.000.000 -11.79%
2023 0 0%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

CKD Corporation Capital Expenditure
Year Capital Expenditure Growth
2004 2.076.000.000
2005 3.571.000.000 41.87%
2006 3.709.000.000 3.72%
2007 8.585.000.000 56.8%
2008 2.160.000.000 -297.45%
2009 917.000.000 -135.55%
2010 1.001.000.000 8.39%
2011 3.231.000.000 69.02%
2012 2.990.000.000 -8.06%
2013 3.847.000.000 22.28%
2014 6.044.000.000 36.35%
2015 7.556.000.000 20.01%
2016 5.242.000.000 -44.14%
2017 8.128.000.000 35.51%
2018 16.310.000.000 50.17%
2019 4.081.000.000 -299.66%
2020 2.958.000.000 -37.96%
2021 8.237.000.000 64.09%
2022 11.751.000.000 29.9%
2023 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

CKD Corporation Equity
Year Equity Growth
2004 30.261.000.000
2005 38.046.000.000 20.46%
2006 44.964.000.000 15.39%
2007 45.493.000.000 1.16%
2008 39.594.000.000 -14.9%
2009 41.480.000.000 4.55%
2010 45.335.000.000 8.5%
2011 48.322.000.000 6.18%
2012 50.852.000.000 4.98%
2013 57.711.000.000 11.89%
2014 65.554.000.000 11.96%
2015 66.418.000.000 1.3%
2016 70.956.000.000 6.4%
2017 80.056.000.000 11.37%
2018 80.444.000.000 0.48%
2019 82.462.000.000 2.45%
2020 97.615.000.000 15.52%
2021 109.570.000.000 10.91%
2022 119.730.000.000 8.49%
2023 123.052.000.000 2.7%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

CKD Corporation Assets
Year Assets Growth
2004 67.967.000.000
2005 71.719.000.000 5.23%
2006 86.592.000.000 17.18%
2007 75.207.000.000 -15.14%
2008 62.802.000.000 -19.75%
2009 62.869.000.000 0.11%
2010 72.171.000.000 12.89%
2011 70.079.000.000 -2.99%
2012 71.742.000.000 2.32%
2013 86.711.000.000 17.26%
2014 96.018.000.000 9.69%
2015 96.412.000.000 0.41%
2016 106.361.000.000 9.35%
2017 132.820.000.000 19.92%
2018 136.961.000.000 3.02%
2019 136.059.000.000 -0.66%
2020 152.726.000.000 10.91%
2021 172.514.000.000 11.47%
2022 185.626.000.000 7.06%
2023 203.808.000.000 8.92%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

CKD Corporation Liabilities
Year Liabilities Growth
2004 37.671.000.000
2005 33.673.000.000 -11.87%
2006 41.628.000.000 19.11%
2007 29.714.000.000 -40.1%
2008 23.208.000.000 -28.03%
2009 21.389.000.000 -8.5%
2010 26.836.000.000 20.3%
2011 21.757.000.000 -23.34%
2012 20.890.000.000 -4.15%
2013 29.000.000.000 27.97%
2014 30.464.000.000 4.81%
2015 29.994.000.000 -1.57%
2016 35.405.000.000 15.28%
2017 52.764.000.000 32.9%
2018 56.517.000.000 6.64%
2019 53.597.000.000 -5.45%
2020 55.111.000.000 2.75%
2021 62.944.000.000 12.44%
2022 65.896.000.000 4.48%
2023 80.756.000.000 18.4%

CKD Corporation Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
2185.19
Net Income per Share
175.55
Price to Earning Ratio
14.77x
Price To Sales Ratio
1.19x
POCF Ratio
0
PFCF Ratio
0
Price to Book Ratio
1.41
EV to Sales
1.21
EV Over EBITDA
10.06
EV to Operating CashFlow
0
EV to FreeCashFlow
0
Earnings Yield
0.07
FreeCashFlow Yield
0
Market Cap
173,94 Bil.
Enterprise Value
176,94 Bil.
Graham Number
2699.33
Graham NetNet
29

Income Statement Metrics

Net Income per Share
175.55
Income Quality
0
ROE
0.1
Return On Assets
0.05
Return On Capital Employed
0.09
Net Income per EBT
0.67
EBT Per Ebit
1.01
Ebit per Revenue
0.1
Effective Tax Rate
0.33

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.28
Operating Profit Margin
0.1
Pretax Profit Margin
0.11
Net Profit Margin
0.07

Dividends

Dividend Yield
0.03
Dividend Yield %
2.82
Payout Ratio
0
Dividend Per Share
73

Operating Metrics

Operating Cashflow per Share
0
Free CashFlow per Share
0
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0.07
Return on Tangible Assets
0.06
Days Sales Outstanding
59.76
Days Payables Outstanding
64.41
Days of Inventory on Hand
214.53
Receivables Turnover
6.11
Payables Turnover
5.67
Inventory Turnover
1.7
Capex per Share
0

Balance Sheet

Cash per Share
513,75
Book Value per Share
1.844,72
Tangible Book Value per Share
1844.72
Shareholders Equity per Share
1844.72
Interest Debt per Share
565.34
Debt to Equity
0.3
Debt to Assets
0.18
Net Debt to EBITDA
0.17
Current Ratio
2.81
Tangible Asset Value
121,31 Bil.
Net Current Asset Value
47,78 Bil.
Invested Capital
0.3
Working Capital
82,82 Bil.
Intangibles to Total Assets
0.01
Average Receivables
28,57 Bil.
Average Payables
19,14 Bil.
Average Inventory
60170000000
Debt to Market Cap
0.21

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

CKD Corporation Dividends
Year Dividends Growth
2001 9
2002 9 0%
2003 9 0%
2004 6 -50%
2005 13 53.85%
2006 18 27.78%
2007 25 28%
2008 22 -13.64%
2009 8 -175%
2010 9 11.11%
2011 14 35.71%
2012 11 -27.27%
2013 13 15.38%
2014 21 38.1%
2015 26 19.23%
2016 27 3.7%
2017 33 18.18%
2018 40 17.5%
2019 13 -207.69%
2020 21 38.1%
2021 45 53.33%
2022 78 42.31%
2023 73 -6.85%
2024 0 0%

CKD Corporation Profile

About CKD Corporation

CKD Corporation develops, manufactures, sells, and exports automation machinery, drive components, pneumatic control components, pneumatic auxiliary components, and fluid control components worldwide. It operates through Automatic Machinery and Component Products segments. The company offers a range of products, including packaging machines for medical, pharmaceutical, and food products; industrial machinery for lithium-ion battery winding and solder paste inspection machines; and lamp equipment. It also provides labor-saving components, such as index units, direct drive motors, and pick and place units; pneumatic control components comprising directional control values; and drive components, which include pneumatic cylinders, assistance devices, and hand chucks. In addition, the company offers fine system components; and fluid control components, including valves and unit system components to control and utilize fluids. The company was formerly known as Chukyo Electric Co., Ltd. and changed its name to CKD Corporation in July 1979. CKD Corporation was incorporated in 1943 and is headquartered in Komaki, Japan.

CEO
Mr. Kazunori Kajimoto
Employee
4.684
Address
250, Ouji 2-chome
Komaki, 485-8551

CKD Corporation Executives & BODs

CKD Corporation Executives & BODs
# Name Age
1 Mr. Katsuhito Okuoka
President, Chief Operating Officer & Representative Director
70
2 Mr. Shinji Yuhara
Executive Officer, GM of Components Sales & Marketing Div and DGM of Components Business Div
70
3 Tadashi Takezawa
Accounting Manager
70
4 Mr. Katsunori Hayashida
Managing Executive Officer & GM of Components Business Division
70
5 Mr. Kazunori Kajimoto
Chairperson & Chief Executive Officer
70
6 Mr. Yusuke Hirako
Director, Managing Executive Officer & Chief Financial Officer
70
7 Mr. Kazuhide Okada
Executive Officer & GM of Personnel Department
70

CKD Corporation Competitors

THK Co., Ltd. Logo
THK Co., Ltd.

6481.T

(1.8)
SMC Corporation Logo
SMC Corporation

6273.T

(4.0)
Nabtesco Corporation Logo
Nabtesco Corporation

6268.T

(2.2)
Taiyo Yuden Co., Ltd. Logo
Taiyo Yuden Co., Ltd.

6976.T

(2.8)